XML 18 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Total revenue $ 622,489 $ 3,915,160
Cost of revenue 222,377 999,124
Gross profit 400,112 2,916,036
Operating expenses    
Sales and marketing 2,381,131 4,483,339
General and administrative 9,058,283 16,157,152
Research and development 19,137,242 20,979,589
Depreciation and amortization 1,106,808 1,377,266
Impairment charges 18,882,000
Total operating expenses 50,565,464 42,997,346
Loss from operations (50,165,352) (40,081,310)
Other income, net    
Interest income, net 292,932 1,091,825
Realized gain on investments 683,365 870,745
Gain (loss) on disposition of assets (82,421) 8,291
Gain on remeasurement of acquisition contingencies 805,863 714,876
Loss on equity method investment in joint ventures (46,301) (186,067)
Total other income, net 1,653,438 2,499,670
Loss before income taxes (48,511,914) (37,581,640)
Income tax provision (benefit) (1,615,978) 57,368
Net loss (46,895,936) (37,639,008)
Other comprehensive income (loss)    
Change in net unrealized gains (losses) on marketable securities, net of tax (418,443) 271,743
Total other comprehensive income (loss) (418,443) 271,743
Comprehensive loss $ (47,314,379) $ (37,367,265)
Loss per common share:    
Basic $ (35.25) $ (37.22)
Diluted $ (35.25) $ (37.22)
Weighted average shares outstanding:    
Basic 1,330,200 1,011,179
Diluted 1,330,200 1,011,179
Product [Member]    
Total revenue $ 418,205 $ 770,048
Grant [Member]    
Total revenue $ 204,284 $ 3,145,112